| 1. |
Gould DB, Phalan FC, Breedveld GJ, et al. Mutations in Col4a1 cause perinatal cerebral hemorrhage and porencephaly. Science, 2005, 308(5725): 1167-1171.
|
| 2. |
Breedveld G, de Coo IF, Lequin MH, et al. Novel mutations in three families confirm a major role of COL4A1 in hereditary porencephaly. J Med Genet, 2006, 43(6): 490-495.
|
| 3. |
Itai T, Miyatake S, Taguri M, et al. Prenatal clinical manifestations in individuals with COL4A1/2 variants. J Med Genet, 2021, 58(8): 505-513.
|
| 4. |
Wang QH, Zou LP, Zhang MN, et al. Phenotypic characterization of COL4A1-related West syndrome. Epilepsy Res, 2020, 164: 106349.
|
| 5. |
Zagaglia S, Selch C, Nisevic JR, et al. Neurologic phenotypes associated with COL4A1/2 mutations: Expanding the spectrum of disease. Neurology, 2018, 91(22): e2078-e2088.
|
| 6. |
Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med, 2015, 17(5): 405-424.
|
| 7. |
Labelle-Dumais C, Schuitema V, Hayashi G, et al. COL4A1 Mutations cause neuromuscular disease with tissue-specific mechanistic heterogeneity. Am J Hum Genet, 2019, 104(5): 847-860.
|
| 8. |
Murray LS, Lu Y, Taggart A, et al. Chemical chaperone treatment reduces intracellular accumulation of mutant collagen IV and ameliorates the cellular phenotype of a COL4A2 mutation that causes haemorrhagic stroke. Hum Mol Genet, 2014, 23(2): 283-292.
|
| 9. |
Wang T, Jin H, Hu J, et al. COL4A1 promotes the growth and metastasis of hepatocellular carcinoma cells by activating FAK-Src signaling. J Exp Clin Cancer Res, 2020, 39(1): 148.
|
| 10. |
Shin HJ, Gil M, Lee IS. Association of elevated expression levels of COL4A1 in stromal cells with an immunosuppressive tumor microenvironment in low-grade glioma, pancreatic adenocarcinoma, skin cutaneous melanoma, and stomach adenocarcinoma. J Pers Med, 2022, 12(4): 534.
|
| 11. |
Cui X, Shan T, Qiao L. Collagen type IV alpha 1 (COL4A1) silence hampers the invasion, migration and epithelial-mesenchymal transition (EMT) of gastric cancer cells through blocking Hedgehog signaling pathway. Bioengineered, 2022, 13(4): 8972-8981.
|
| 12. |
Li N, Zhou P, Tang H, et al. In-depth analysis reveals complex molecular aetiology in a cohort of idiopathic cerebral palsy. Brain, 2022, 145(1): 119-141.
|
| 13. |
Gubana F, Christov C, Coste T, et al. Prenatal diagnosis of COL4A1 mutations in eight cases: further delineation of the neurohistopathological phenotype. Pediatr Dev Pathol, 2022, 25(4): 435-446.
|
| 14. |
Hino-Fukuyo N, Kikuchi A, Iwasaki M, et al. Dramatic response after functional hemispherectomy in a patient with epileptic encephalopathy carrying a de novo COL4A1 mutation. Brain Dev, 2017, 39(4): 337-340.
|
